Breaking News Instant updates and real-time market news.

DUK

Duke Energy

$87.20

0.7 (0.81%)

06:53
05/20/19
05/20
06:53
05/20/19
06:53

JPMorgan still cautious on Duke Energy despite share pullback

JPMorgan analyst Christopher Turnure says he remains cautious on shares of Duke Energy despite the recent selloff. South Carolina's regulatory environment "has taken a turn for the worse after recent DEP and DEC rulings, and the ACP project remains in limbo," Turnure tells investors in a research note. The analyst sees further risk to estimates and lowered his price target for Duke shares to $90 from $91. He keeps a Neutral rating on the name.

  • 20

    May

  • 21

    May

  • 21

    May

DUK Duke Energy
$87.20

0.7 (0.81%)

01/09/19
01/09/19
DOWNGRADE
Target $87

Neutral
Duke Energy downgraded to Neutral on valuation, pipeline risks at BofA/Merrill
As previously reported, BofA/Merrill downgraded Duke Energy to Neutral from Buy and trimmed its price target to $87 from $88. Analyst Julien Dumoulin-Smith cites valuation, potential further dleays and cost overruns for the Atlantic Coast Pipeline, and limited near-term catalysts for the downgrade.
02/15/19
FBCO
02/15/19
DOWNGRADE
FBCO
Neutral
Duke Energy downgraded to Neutral from Outperform at Credit Suisse
02/15/19
FBCO
02/15/19
DOWNGRADE
Target $88
FBCO
Neutral
Duke Energy downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Michael Weinstein downgraded Duke Energy to Neutral from Outperform and lowered his price target to $88 from $89 following the "lower quality earnings mix" within the new five-year guidance. In a research note to investors, Weinstein says 2019 and forward EPS growth will reflect at least 16c per share more Commercial Renewable tax credits than w expected, offset by (10c) lower regulated utility earnings than he had previously modeled. Additionally, he expects Duke's smaller CR pipeline will likely produce uneven and "lumpy" future results that will come under pressure as tax credit programs sunset through 2023.
05/13/19
BOFA
05/13/19
DOWNGRADE
BOFA
Underperform
Duke Energy downgraded to Underperform from Neutral at BofA/Merrill

TODAY'S FREE FLY STORIES

SNV

Synovus

$33.01

0.08 (0.24%)

07:15
06/17/19
06/17
07:15
06/17/19
07:15
Conference/Events
Synovus management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

, PFE

Pfizer

$42.75

0.24 (0.56%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Breaking Hot Stocks news story on Array BioPharma, Pfizer »

Array BioPharma up 59% to…

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

PFE

Pfizer

$42.75

0.24 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

ALNY

Alnylam

$70.04

-1.15 (-1.62%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Alnylam announces lumasiran results, full patient enrollment in ILLUMINATE-A, »

Alnylam announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$11.35

-0.31 (-2.66%)

07:13
06/17/19
06/17
07:13
06/17/19
07:13
Initiation
Amicus initiated  »

Amicus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 16

    Sep

PLX

Protalix

$0.42

-0.017 (-3.89%)

07:13
06/17/19
06/17
07:13
06/17/19
07:13
Hot Stocks
Protalix completes enrollment in Phase III Bright clinical trial of PRX-102 »

Protalix BioTherapeutics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$364.63

-0.43 (-0.12%)

07:12
06/17/19
06/17
07:12
06/17/19
07:12
Conference/Events
Roper Technologies management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

07:12
06/17/19
06/17
07:12
06/17/19
07:12
Initiation
Rattler Midstream initiated  »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RWLK

ReWalk Robotics

$5.21

-0.215 (-3.97%)

07:11
06/17/19
06/17
07:11
06/17/19
07:11
Upgrade
ReWalk Robotics rating change  »

ReWalk Robotics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORGS

Orgenesis

$4.21

-0.09 (-2.09%)

07:11
06/17/19
06/17
07:11
06/17/19
07:11
Hot Stocks
Orgenesis gets Orphan Drug designation for Autologous Insulin Producing cells »

Orgenesis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBMG

Cellular Biomedicine

$14.68

-0.62 (-4.05%)

07:09
06/17/19
06/17
07:09
06/17/19
07:09
Hot Stocks
Cellular Biomedicine: First patient dosed in Phase 1 trial of anti-CD20 CAR-T »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$14.10

0.06 (0.43%)

07:08
06/17/19
06/17
07:08
06/17/19
07:08
Hot Stocks
Universal Stainless & Alloy reports fire at North Jackson, Ohio facility »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$8.24

-0.37 (-4.30%)

07:08
06/17/19
06/17
07:08
06/17/19
07:08
Recommendations
Teva analyst commentary  »

Teva price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$117.48

-7.52 (-6.02%)

, CELG

Celgene

$96.49

0.07 (0.07%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Hot Stocks
BeiGene, Celgene to terminate global collaboration for tislelizumab »

BeiGene (BGNE) announced…

BGNE

BeiGene

$117.48

-7.52 (-6.02%)

CELG

Celgene

$96.49

0.07 (0.07%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

TWIN

Twin Disc

$14.02

0.125 (0.90%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Hot Stocks
Twin Disc names James Feiertag as president and COO, effective May 1 »

Twin Disc has appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

, FANG

Diamondback Energy

$98.98

-1.15 (-1.15%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Initiation
Rattler Midstream, Diamondback Energy initiated  »

Rattler Midstream…

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

FANG

Diamondback Energy

$98.98

-1.15 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 13

    Sep

TYPE

Monotype Imaging

$16.33

0.01 (0.06%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Hot Stocks
Monotype Imaging CFO Anthony Callini to step down »

Monotype Imaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Initiation
Rattler Midstream initiated  »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
06/17/19
06/17
07:05
06/17/19
07:05
General news
FX Update: Trading has been directionally unambitious »

FX Update: Trading has…

CASI

Casi Pharmaceuticals

$3.13

-0.05 (-1.57%)

07:04
06/17/19
06/17
07:04
06/17/19
07:04
Hot Stocks
Casi Pharmaceuticals acquires rights to commercialize anti-CD19 T-cell therapy »

CASI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

IDYA

Ideaya Biosciences

$10.70

-0.1 (-0.93%)

07:04
06/17/19
06/17
07:04
06/17/19
07:04
Initiation
Ideaya Biosciences initiated  »

Ideaya Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$56.60

-0.82 (-1.43%)

07:04
06/17/19
06/17
07:04
06/17/19
07:04
Hot Stocks
Stifel Financial to acquire capital markets business of GMP Capital »

Stifel Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

ENDP

Endo

$4.04

-0.43 (-9.62%)

07:02
06/17/19
06/17
07:02
06/17/19
07:02
Downgrade
Endo rating change  »

Citi downgrades Endo to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDC

China Lending Corp.

$0.92

(0.00%)

07:02
06/17/19
06/17
07:02
06/17/19
07:02
Hot Stocks
China Lending Corp. to acquire equity interests in Cayman Lixin »

China Lending announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$42.75

0.24 (0.56%)

, ARRY

Array BioPharma

$29.59

0.17 (0.58%)

07:01
06/17/19
06/17
07:01
06/17/19
07:01
Hot Stocks
Pfizer to acquire Array BioPharma for $48.00 per share »

Pfizer (PFE) and Array…

PFE

Pfizer

$42.75

0.24 (0.56%)

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

QURE

uniQure

$72.65

1.27 (1.78%)

, PFE

Pfizer

$42.75

0.24 (0.56%)

06:59
06/17/19
06/17
06:59
06/17/19
06:59
Periodicals
uniQure exploring options, including potential sale, Bloomberg reports »

Gene-therapy firm UniQure…

QURE

uniQure

$72.65

1.27 (1.78%)

PFE

Pfizer

$42.75

0.24 (0.56%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

NVO

Novo Nordisk

$50.96

-0.73 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 26

    Jun

  • 28

    Aug

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.